These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 32276137)

  • 21. Pathophysiology and treatment strategies for COVID-19.
    Kumar M; Al Khodor S
    J Transl Med; 2020 Sep; 18(1):353. PubMed ID: 32933536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Audio Interview: Operation Warp Speed and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Aug; 383(9):e79. PubMed ID: 32846078
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19: Progress in diagnostics, therapy and vaccination.
    Liu X; Liu C; Liu G; Luo W; Xia N
    Theranostics; 2020; 10(17):7821-7835. PubMed ID: 32685022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.
    Keam S; Megawati D; Patel SK; Tiwari R; Dhama K; Harapan H
    Rev Med Virol; 2020 Sep; 30(5):e2123. PubMed ID: 32648313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867
    [No Abstract]   [Full Text] [Related]  

  • 26. The post-lockdown period should be used to acquire effective therapies for future resurgence in SARS-Cov-2 infections.
    Krause KL; Furneaux R; Benjes P; Brimble M; Davidson T; Denny W; Harris L; Hinkley S; Tyler P; Ussher JE; Ward V
    N Z Med J; 2020 Apr; 133(1513):107-111. PubMed ID: 32325475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Convalescent Plasma: Promise for COVID-19 Pandemic.
    Sheikh S; Baig MA
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
    [No Abstract]   [Full Text] [Related]  

  • 28. COVID-19 Pandemic: Saudi Arabia's Role at National and International Levels.
    Meo SA
    J Diabetes Sci Technol; 2020 Jul; 14(4):758-759. PubMed ID: 32506934
    [No Abstract]   [Full Text] [Related]  

  • 29. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of current clinical management guidelines for COVID-19 with special reference to India.
    Kumar R; Vinod KS; Mittal A; Adhikari SD; Gupta N
    Drug Discov Ther; 2020; 14(4):171-176. PubMed ID: 32908072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
    Banerjee AK; Arora N
    Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
    [No Abstract]   [Full Text] [Related]  

  • 32. Audio Interview: Covid-19 and the President.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(15):e104. PubMed ID: 33027580
    [No Abstract]   [Full Text] [Related]  

  • 33. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic.
    Lee NY; Li CW; Tsai HP; Chen PL; Syue LS; Li MC; Tsai CS; Lo CL; Hsueh PR; Ko WC
    J Microbiol Immunol Infect; 2020 Jun; 53(3):485-487. PubMed ID: 32198005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-dependent enhancement and COVID-19: Moving toward acquittal.
    Yager EJ
    Clin Immunol; 2020 Aug; 217():108496. PubMed ID: 32526272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
    Kouzy R; Abi Jaoude J; Garcia Garcia CJ; El Alam MB; Taniguchi CM; Ludmir EB
    JAMA Netw Open; 2020 Jul; 3(7):e2015100. PubMed ID: 32658285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. China's successful control of COVID-19.
    Burki T
    Lancet Infect Dis; 2020 Nov; 20(11):1240-1241. PubMed ID: 33038941
    [No Abstract]   [Full Text] [Related]  

  • 37. Does the hygiene hypothesis apply to COVID-19 susceptibility?
    Sehrawat S; Rouse BT
    Microbes Infect; 2020 Oct; 22(9):400-402. PubMed ID: 32653475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-2019: update on epidemiology, disease spread and management.
    Sahu KK; Mishra AK; Lal A
    Monaldi Arch Chest Dis; 2020 Apr; 90(1):. PubMed ID: 32297723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
    Morabito CJ; Gangadharan B
    Clin Transl Sci; 2020 Sep; 13(5):835-837. PubMed ID: 32420691
    [No Abstract]   [Full Text] [Related]  

  • 40. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
    Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
    Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.